Yongkang Wu

Suggest Changes
Learn More
WHAT IS KNOWN AND OBJECTIVE Rituximab, an anti-CD20 monoclonal antibody, is widely used with good response for the treatment of B-cell lymphoma and various refractory autoimmune diseases. Although(More)